Dear ISHers,

Please find below a few announcements
(1) PSA - ISHPSSB cognate session
(2) PSA - The International Philosophy of Medicine Roundtable cognate
session
(3) CfP - Conference "Evidence-Based Medicine Reconsidered"

Have a good day,
Lucie


*(1) PSA - ISHPSSB cognate session*
Dear ISH Community,

If you are attending the PSA conference in New Orleans this week, we warmly
invite you to join the ISHPSSB cognate session, entitled "Into the Red:
Philosophical Issues in Risk Categorisation, Classification, and Concept
Formation at the Edge of Extinction":

*Date & Time*: Thursday at 10:15 AM
*Location: *Studio 4
*Abstract*: Together with the climate crisis, the biodiversity crisis is at
the center of global risk assessment and scenario-building exercises at the
science-policy interface. But unlike the climate crisis, the biodiversity
crisis has received scant attention from philosophers of science interested
in the complex epistemic and ethical roles of non- and intergovernmental
actors that govern these large-scale scientific endeavors. This symposium
seeks to address this gap by critically examining the assessment tools,
conceptual framings, and classification strategies of the International
Union for Conservation of Nature (IUCN). As the producer of the
authoritative Red List of Threatened Species (RLS) and Red List of
Threatened Ecosystems (RLE), the IUCN plays a pivotal role in setting the
conceptual and ethical stage for science-policy interventions that aim to
mitigate the biodiversity crisis. This symposium will address the tensions
between conceptualizations of ‘care’ and ‘objectivity’ that inform the
governance structure of the RLS (Beckett Sterner), analyze the problematic
effects of performativity that result from the uptake of the RLS risks
categorization in conservation practice (Joeri Witteveen), examine the
trade-offs between global and local classification schemes for conservation
units (Lara Sabatier), and develop a new account of the notion of
‘ecosystem collapse’ that is at the heart of the RLE (Max Dresow and
Michael Bennett McNulty).

We look forward to seeing many of you there!

Best regards,

Joeri Witteveen

*(2) PSA - The International Philosophy of Medicine Roundtable cognate
session*

The International Philosophy of Medicine Roundtable cognate session will
take place on Thursday 14 November from 8:30-10:00 am in Studio 4. The
topic is "What can HPS and STS contribute to debates about replacing
experimental animals with NAMs?"

The session will include:
- The uncertain ontological status of organoids by Charles H. Pence
(presenter) and Maxence Gaillard
- Using a repertoires framework to understand impediments and drivers of
alternatives to animal research models by Rachel A. Ankeny
- Facing NAMs: Exploring the potentials of human and other-than-human
encounters in the building of non-animal models for neuroscience research
by Sophia Efstathiou (presenter), Emma Roe, and Ioanna Sandvig
- Commentary by Sara Green followed by audience and panel discussion

For more details, please see the PSA program at
https://site.pheedloop.com/event/psa24/program/schedule.

We look forward to seeing you there!

*(3) CfP - Conference "Evidence-Based Medicine Reconsidered"*
*CALL FOR PAPERS  - Deadline is November 17*

*Conference Dates: April 5-6th, 2025*

University of Pittsburgh, Pittsburgh, PA



Senior Visiting Fellow Conference by Carl Hoefer

The evidence-based medicine (EBM) movement began in the 1980s, reached its
peak perhaps in the 1990s, and has since then enjoyed the status of
orthodoxy, despite many criticisms being raised among medical practitioners
and researchers. Philosophers of medicine have frequently criticized EBM’s
hierarchies and rigid precepts, especially the “gold standard” status of
randomized controlled trials (RCTs). A pluralistic approach to evidence in
medicine has been increasingly popular in recent years, in which
mechanistic evidence and reasoning, observational studies of many kinds and
RCTs are assessed for value on a case-by-case basis. But does this trend
away from the EBM hierarchy go too far and risk the reintroduction of the
same biased, motivated evidence-gathering practices that originally
motivated the EBM movement? What light can recent experiences in medicine
and public health (e.g., during the covid-19 pandemic) shed on these issues?



Visit the website for the most up-to- date information and registration:
https://www.centerphilsci.pitt.edu/event/evidence-based-medicine-reconsidered/

*Call for Abstracts*

We invite papers which address topics related to evidence in medicine,
broadly speaking. These include, but are not limited to:

   - Defenses (or criticisms) of the supposed superiority of RCTs over
   observational studies, mechanistic studies, modeling, and individual
   clinical judgment;
   - Discussions of lessons that philosophy of medicine or EBM can learn
   from recent experiences;
   - Papers offering theoretical discussions of procedures for integrating
   and evaluating evidence from different sources;
   - The merits and limitations of emerging kinds of medical evidence, such
   as adaptive trials, so-called real-world evidence, precision or
   personalized medicine research, and big data research
   - Evidence in diverse contexts, such as clinical practice, alternative
   healthcare, drug or device regulation, public health, and health policy.

*Abstracts should be between 500-800 words long and should be sent by
November 17th to:* [log in to unmask]